A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma, remains a devastating
disease with a dismal prognosis and limited survival rates. Despite various drug treatments …
disease with a dismal prognosis and limited survival rates. Despite various drug treatments …